Efficacy and safety of switching from adalimumab to baricitinib: long-term data from phase 3 extension study in patients with rheumatoid arthritis

Efficacy and safety of switching from adalimumab to baricitinib: long-term data from phase 3 extension study in patients with rheumatoid arthritis

Bibliographic Details
Main Authors: Weinblatt, M, Taylor, P, Keystone, E, Ortmann, R, Issa, M, Xie, L, de Bono, S, Tanaka, Y
Format: Conference item
Published: Wiley 2018

Similar Items